This site uses cookies. To find out more, see our Cookies Policy

Associate Director, Medical Affairs Oncology, Biomarkers and CDx in Bernards, NJ at DSI

Date Posted: 5/2/2019

Job Snapshot

Job Description

Join a Legacy of Innovation 110 Years and Counting!

With over 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 15,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people. In addition to a strong portfolio of medicines for hypertension and thrombotic disorders, under the Group’s 2025 Vision to become a “Global Pharma Innovator with a Competitive Advantage in Oncology,” Daiichi Sankyo research and development is primarily focused on bringing forth novel therapies in oncology, including immuno-oncology, with additional focus on new horizon areas, such as pain management, neurodegenerative diseases, heart and kidney diseases, and other rare diseases.

Job Summary:

The Associate Director, US Medical Affairs Oncology Biomarkers and Companion Diagnostics will be responsible for the development and execution of US medical affairs biomarkers and cDX strategy for Daiichi Sankyo’s oncology pipeline portfolio of assets across platforms and tumor types. The Associate Director, US Medical Affairs Oncology Biomarkers and Companion Diagnostics will work closely with cross-functional partners and Global for coordination of biomarker diagnostic activities. This role will collaborate with relevant US medical affairs leads, cross-functionally, and with Global to develop and execute the US medical affairs strategy for biomarkers and cDx. Incumbent will participate in/lead advisory boards, conduct individual meetings with key external experts in support of the oncology portfolio, and lead medical biomarker strategy around US regional oncology congresses. This role will also interact with professional societies and advocacy groups for coordination of activities around biomarker education and awareness. This individual will also review Investigator Sponsored Study proposals and other types of research proposals related to or involving biomarkers and diagnostics and determine resource and budget allocation needed to deliver on US medical strategies.

Responsibilities:
  • Cross-functional collaboration to ensure strategic, timely and appropriate scientific communication and engagement activities for biomarkers and diagnostics at major congresses, medical meetings, and other venues; ensure timely release of data supporting core development areas; assure high quality outputs as well as compliance with appropriate internal and external publication practices.
  • Responsible for planning/contributing to and execution of (in collaboration with stakeholders as appropriate) advisory meetings to enhance biomarker and diagnostics strategies and contribution of the Oncology portfolio to patient care and corporate presence.
  • In collaboration with US medical affairs leads, Global and R&D, support assessment of brand IISs as needed for biomarkers and diagnostics. Provide guidance to Office of Grants and Education regarding priorities for CME and non-CME educational grants. Additionally, in collaboration with cross-functional stakeholders, develop and implement thought leader engagement plans and ensure the tactical implementation is consistent with company SOPs, rules and regulations.
  • Collaborate with internal stakeholders in the development of appropriate Medical Affairs plans to support biomarker and diagnostics strategies. Also responsible for training needs of field-based Medical Science Liaisons including the development of training materials and appropriate sessions to maintain high level of clinical expertise in the field of oncology. Additionally, collaborate with development and Global teams through participation in Global Brand Teams and support global medical affairs efforts as a participant and leader of Global Medical Affairs Committees as appropriate
  • Ensure the appropriate utilization of financial and other resources required to achieve the medical objectives; and effectively managing project specific and administrative budgets.
Qualifications
Successful candidates will be able to meet the qualifications below with or without a reasonable accommodation.

Education/Experience:
  • Advanced degree in the Health Sciences, such as PharmD, PhD from an accredited college or university is required; training or experience in pathology and/or diagnostics and biomarkers is preferred
  • Minimum of 3 years of relevant pharmaceutical industry, clinical, and/or academic experience. Proven track record of working successfully with cross-functional teams to achieve goals. Experience with medical strategies and scientific research/communication plans is required.
  • Understanding of pharmaceutical business, drug development, biomarkers/diagnostics and regulatory process. Demonstrated understanding of legal and regulatory guidelines of pharmaceutical industry. Familiarity with FDA breakthrough designation or orphan drug status desired, but not required.
  • Independent thinking, creativity and innovation. Ability to deliver high quality products.
  • Strong interpersonal skills and ability to interface effectively with multinational development teams in a multicultural working environment.
  • Excellent communication, presentation and negotiation skills with emphasis on building consensus.
  • Ability to effectively develop relationships with academic thought leaders ensuring optimal cooperation for achieving program and department goals.
  • Ability to understand different business models and matrix structures to maximize translation and effective execution of business plans to enhance brand and corporate strategies and tactics
  • Proven track record of strong strategic leadership, teamwork, innovation, project management and demonstrated ability to manage, lead and mentor individuals
Daiichi Sankyo, Inc. is an equal opportunity/affirmative action employer. Qualified applicants will receive consideration for employment without regard to sex, gender identity, sexual orientation, race, color, religion, national origin, disability, protected veteran status, age, or any other characteristic protected by law.